The clinical results of a platelet glycoprotein IIb/IIIa receptor blocker (Abciximab: ReoPro)-coated stent in acute myocardial infarction

Journal of the American College of Cardiology

Volumn 47, Issue 5, 2006, Pages 933-938

  Kim, Weon ^a   Jeong, Myung Ho ^a   Kim, Kye Hun ^a   Sohn, Il Suk ^a   Hong, Young Joon ^a   Park, Hyung Wook ^a   Kim, Ju Han ^a   Ahn, Young Keun ^a   Cho, Jeong Gwan ^a   Park, Jong Chun ^a   Cho, Dong Lyun ^b   Kang, Jung Chae ^a  

^a Chonnam National University Medical School   (South Korea)

^b Chonnam National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BRAIN HEMORRHAGE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ELUTING STENT; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; GINGIVA BLEEDING; HEART MUSCLE REVASCULARIZATION; HEART REINFARCTION; HOSPITALIZATION; HUMAN; INTRAVASCULAR ULTRASOUND; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; STROKE; THROMBOCYTOPENIA; URINARY TRACT HEMORRHAGE;

ANTIBODIES, MONOCLONAL; COMBINED MODALITY THERAPY; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; DRUG CARRIERS; FEMALE; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PROSPECTIVE STUDIES; STENTS;

EID: 33644625730     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2005.10.054     Document Type: Article

References (26)

1. P.W. Serruys, P.D. Jaegere, F. Kiemeneij BENESTENT study group A comparison of balloon-expandable stent implantation with balloon angioplasty in patients with coronary heart disease N Engl J Med 331 1994 489 495
2. A. Kastrati, A. Dibra, S. Eberle Sirolimus-eluting stents vs paclitaxel-eluting stents in patients with coronary artery disease meta-analysis of randomized trials JAMA 294 2005 819 825
3. M.-C. Morice, P.W. Serruy, J.E. Sousa RAVEL Study Group A randomized comparison of a sirolimus-eluting stent with standard stent for coronary revascularization N Engl J Med 346 2002 1773 1780
4. I. Moussa, M.B. Leon, D.S. Baim Impact of sirolimus-eluting stents on outcome in diabetic patients a SIRIUS substudy Circulation 109 2004 2273 2278
5. M. Degertekin, C.A. Arampatzis, P.A. Lemos Very long sirolimus-eluting stent implantation for de novo coronary lesions Am J Cardiol 93 2004 826 829
6. P.A. Lemos, A. Hoye, D. Goedhart Clinical, angiographic, and procedural predictors of angiographic restenosis after sirolimus-eluting stent implantation in complex patients an evaluation from the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) study Circulation 109 2004 1366 1370
7. J. Schofer, M. Schluter, A.H. Gershlick E-SIRIUS Investigators Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries double-blind, randomised controlled trial (E-SIRIUS) Lancet 362 2003 1093 1099
8. EPIC Investigators Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty N Engl J Med 330 1994 956 961
9. EPILOG Investigators Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization N Engl J Med 336 1997 1689 1696
10. CAPTURE Investigators Randomized placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina Lancet 349 1997 1429 1435
11. Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Sings and Symptoms (PRISM-PLUS) Study Investigators Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction N Engl J Med 338 1998 1488 1497
12. S.H. Tam, P.M. Sassoi, R.E. Jordan, M.T. Nakada Abciximab (ReoPro, chimeric 7E3 Fab) demonstrates equivalent affinity and functional blockade of glycoprotein IIb/IIIa and alpha(v) beta3 integrins Circulation 98 1998 1085 1091
13. J.C. Reverter, S. Beguin, H. Kessels, R. Kuman, H.C. Hemker, B.S. Coller Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 Fab treatment of an acute thrombosis and "clinical restenosis" J Clin Invest 98 1996 863 874
14. S.B. Shappel, C. Toman, D.C. Anderson, A.A. Taylor, M.L. Entman, C.W. Smith Mac-1 (CD11b/CD8) mediates adherence-dependent hydrogen peroxide production by human and canine neutrophils J Immunol 144 1990 2702 2711
15. D.I. Simon, H. XU, S. Ortelpp, C. Rogers, N.K. Rao 7E3 monoclonal antibody directed against the platelet glycoprotein IIb/IIIa cross-reacts with the leukocyte integrin Mac-1 and blocks adhesion to fibrinogen and ICAM-1 Thromb Vasc Biol 17 1997 528 535
16. J.K. Mickelson, M.N. Ali, N.S. Kleiman, N.M. Lakkis, T.W. Chow, B.J. Hughes Chimeric 7E3 Fab (ReoPro) decreases detectable CD IIb on neutrophils from patients undergoing coronary angioplasty J Am Coll Cardiol 33 1999 97 106
17. J. Lefkovits, E.J. Topol Platelet glycoprotein IIb/IIIa receptor antagonists in coronary artery disease Eur Heart J 17 1996 9 18
18. Y.J. Hong, M.H. Jeong, W. Kim Effect of abciximab-coated stent on in-stent intimal hyperplasia in human coronary arteries Am J Cardiol 94 2004 1050 1054
19. M.H. Jeong, K.T. Kang, Y.K. Ahn ReoPro-coated stent inhibits porcine coronary stent thrombosis and restenosis Circulation 102 2000 II666
20. A.M. Lincoff, D.J. Kereiakes, M.A. Mascelli Abciximab suppresses the rise in levels of circulating inflammatory markers after percutaneous coronary revascularization Circulation 104 2000 163 167
21. M. Schwarz, T. Nordt, C. Bode, K. Peter The GP IIb/IIIa inhibitor abciximab (c7E3) inhibits the binding of various ligands to the leukocyte integrin Mac-1 (CD11b/CD18, alpha(M)beta(2)) Thromb Res 107 2002 121 128
22. C.L. Grines, D.A. Cox, G.W. Stone Stent Primary Angioplasty in Myocardial Infarction Study Group Coronary angioplasty with or without stent implantation for acute myocardial infarction N Engl J Med 341 1999 1949 1956
23. G.W. Stone, C.L. Grines, D.A. Cox Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction; Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Investigators N Engl J Med 346 2002 957 966
24. F. Saia, P.A. Lemos, C.H. Lee Sirolimus-eluting stent implantation in ST-elevation acute myocardial infarction a clinical and angiographic study Circulation 108 2003 1927 1929
25. P.A. Lemos, F. Saia, S.H. Hofma Short- and long-term clinical benefit of sirolimus-eluting stents compared to conventional bare stents for patients with acute myocardial infarction J Am Coll Cardiol 43 2004 704 708
26. A. Jeremias, B. Sylvia, J. Bridges Stent thrombosis after successful sirolimus-eluting stent implantation Circulation 109 2004 1930 1932